Annette K. Taylor, M.S., Ph.D. Of Kimball Genetics, Inc. Appointed to the Newly Formed Department of Veteran Affairs Genomic Medicine Program Advisory Committee
Posted on: Friday, 3 November 2006, 15:01 CST
DENVER, Nov. 3 /PRNewswire/ -- Kimball Genetics, Inc. announces the appointment of Dr. Annette K. Taylor, its President and CEO, to the Department of Veterans Affairs Genomic Medicine Program Advisory Committee. The new committee will help the Department of Veteran Affairs establish policies for using genetic information to optimize medical care of veterans and to enhance development of tests and treatments for diseases common among veterans.
The advisors appointed to the committee are internationally recognized scientists who will advise the Department on emerging issues in genomic medicine. The committee is comprised of nine advisors and is chaired by Dr. Wayne W. Grody, Professor of Pathology and Laboratory Medicine and Pediatrics at the University of California, Los Angeles. The first of three annual meetings took place October 16th in Washington DC.
"The Department of Veterans Affairs has tremendous foresight in launching such an ambitious, broad scope program," says Dr. Taylor. "Using the VA's research and clinical attributes presents an enormous opportunity for advancements in genetic knowledge about common diseases and pharmacogenomics. Integration of this knowledge into health care will benefit veterans as well as the entire nation. I am honored to be a part of this prestigious group of scientific and medical professionals and look forward to the exciting work ahead." Trained at Dartmouth, UCLA, and the University of Colorado Health Sciences Center, Dr. Taylor is board certified in both Clinical Molecular Genetics and Genetic Counseling. This combination of qualifications has led to her conviction that a strong emphasis on genetic counseling and education should be an integral part of genetic testing.
About Kimball Genetics, Inc.
Founded in 1994 by Annette K. Taylor, M.S., Ph.D., Kimball Genetics is a national DNA diagnostic laboratory specializing in testing for common genetic disorders that are preventable or can be treated. Known for its unparalleled turnaround time and distinctive focus on genetic counseling and education, the company's major areas of testing currently include inherited hypercoagulability, celiac disease, hemochromatosis, cystic fibrosis, and fragile X syndrome. Soon they will be expanding their menu to include several pharmocogenomic tests to allow for the personal customization of drug therapy.
Kimball Genetics, Inc.
CONTACT: Michelle Springer of Kimball Genetics, Inc., +1-303-320-1807,or fax, +1-303-388-9220, mspringer@kimballgenetics.com
Source: PRNewswire
Related Articles
- SIGG Hires J&J Veteran Steven G.S. Taylor as New CEO
- VIBE Records Hires Music Industry Veteran Michael Selverne, Esq., as Corporate Counsel
- Gunn Sworn in As Veterans Affairs General Counsel
- PhRMA Applauds House Committee on Foreign Affairs Commitment to Continuing Efforts to Fight AIDS, Tuberculosis, and Malaria Epidemics
- Veterans Committee Picks No One for Hall
- Quest Diagnostics Announces Licensing Agreement for Genetic Testing Technology to Screen for Most Common Inherited Mental Impairment, Fragile X Syndrome
- The Dominion Post, Morgantown, W.Va., Local Briefs Column: Veterans Affairs Services Provided Soon
- Researchers Zero In on Genetic Link to Parkinson's
- Corautus Genetics Announces Steering Committee for GENASIS Trial
- Genetic Links to Psychiatric Disorders
 |
 |
User Comments (0)
RSS Feeds